课题基金 / 基金详情

Regulation of neutrophil function through the pleiotropic receptor FPR2/ALX

Regulation of neutrophil function through the pleiotropic receptor FPR2/ALX
通过多效性受体 FPR2/ALX 调节中性粒细胞功能
批准号:
RGPIN-2017-04980
负责人:
Filep, Janos
金额:
$1.89万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-01-01 至 2020-12-31

项目摘要

项目成果

Filep, Janos的其他基金

相似基金

相关文献

中文摘要
翻译
通过多受体FPR2/ALX调节中性粒细胞功能*******背景和原理:****中性粒细胞(PMNs)在宿主防御感染和组织损伤中发挥核心作用。它们的功能性沉默和及时清除对于炎症的解决至关重要。在炎症问题中,pmn接收多种信号,它们的命运最终取决于这些信号的平衡。有趣的是,这些信号聚集在选定的受体上。这些受体中有甲酰基肽受体2/脂素受体(FPR2/ALX),它能识别异常大量的结构上不相关的分子,包括从垂死细胞线粒体释放的促炎n -甲酰基化肽,以及促进炎症消退的脂质介质、脂素和溶解蛋白D1。我们最近在该领域的研究首次证明了一些FPR2/ALX配体之间的层次关系,以调节PMN的激活和凋亡,这是解决炎症的重要控制点。迄今为止,关于FPR2/ALX如何识别各种配体并对其做出不同反应的分子基础知之甚少。本提案的具体目的是调查:*******1。FPR2/ALX整合来自线粒体n -甲酰化肽和促溶解脂质介质和下游信号通路的对立线索的分子基础。****2。人类PMN对促炎和促溶解FPR2/ALX配体的反应。****各种FPR2/ALX配体调节PMN功能对小鼠细菌感染诱导炎症自发消退的影响* * * * * * *的研究方法:* * * * 1。我们将使用转染FPR2/ALX的HEK293作为模型细胞,利用生物发光共振能量转移(BRET)来探索FPR2/ALX的配体偏态,并进行磷酸化蛋白质组和磷酸酶谱分析,以识别由促溶解脂质介质触发的“停止信号”,以对抗促炎激动剂的作用。****2。我们将通过结合无偏磷酸激酶阵列、免疫印迹和药物抑制剂来评估人类PMN对各种FPR2/ALX配体的反应(超氧化物形成、脱颗粒、吞噬和细菌杀死)和潜在的细胞内信号通路。****3。我们将研究FPR2/ALX配体在大肠杆菌感染引起的野生型和FPR2/ 3-/-(人类FPR2/ALX的同源物)小鼠肺炎症中对PMN功能、寿命和细菌杀伤的相互作用。*******意义:我预计这项研究将显著促进了解FPR2/ALX如何整合控制pmn功能和命运的对立信号,从而影响炎症的结果
英文摘要
Regulation of neutrophil function through the pleiotropic receptor FPR2/ALX*******Background and Rationale:****Neutrophil granulocytes (PMNs) play a central role in host defense to infection and tissue injury. Their functional silencing and timely removal are essential for the resolution of inflammation. In inflamed issues, PMNs receive multiple cues and their fate would ultimately depend on the balance of these signals. Intriguingly, these signals converge on select receptors. Among these receptors is the formyl-peptide receptor 2/lipoxin receptor (FPR2/ALX) that recognizes an unusually large number of structurally unrelated molecules, including pro-inflammatory N-formylated peptides released from mitochondria of dying cells and the lipid mediators, lipoxins and resolvin D1, which promote resolution of inflammation. Our recent studies in the field are the first to demonstrate the hierarchy among some FPR2/ALX ligands to regulate PMN activation and apoptosis, important control points in resolving inflammation. To date, little is known about the molecular basis how FPR2/ALX recognizes and differently responds to various ligands. The specific aims of this proposal are to investigate:*******1. The molecular basis of FPR2/ALX integration of opposing cues from mitochondrial N-formylated peptides and pro-resolving lipid mediators and downstream signalling pathways.****2. Human PMN responses to pro-inflammatory and pro-resolving FPR2/ALX ligands.****3. The impact of modulating PMN functions by various FPR2/ALX ligands on the outcome of spontaneously resolving bacterial infection-induced inflammation in mice.*******Research Approach:****1. We will use HEK293 transfected with FPR2/ALX as model cells to explore ligand biasing of FPR2/ALX using bioluminescence resonance energy transfer (BRET) and to perform phosphoproteome and phosphatase profiling to identify “stop signals” triggered by pro-resolving lipid mediators to counter the actions of pro-inflammatory agonists.****2. We will assess human PMN responses (superoxide formation, degranulation, phagocytosis and bacterial killing) to various FPR2/ALX ligands and the underlying intracellular signalling pathways by combining unbiased phosphokinase arrays, immunoblotting and pharmacological inhibitors.****3. We will study the interplay among FPR2/ALX ligands on PMN function and life span and bacterial killing in E. coli infection-evoked lung inflammation in wild type and fpr2/3-/- (the orthologues of human FPR2/ALX) mice.*******Significance: I anticipate that this study will significantly advance understanding how FPR2/ALX integrates opposing cues that govern the function and fate of PMNs, and consequently the outcome of inflammation.***
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of neutrophil function through the pleiotropic receptor FPR2/ALX
  • 批准号:
    RGPIN-2017-04980
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.79万
  • 财政年份:
    2021
  • 负责人:
    Filep, Janos
  • 依托单位:
Regulation of neutrophil function through the pleiotropic receptor FPR2/ALX
  • 批准号:
    RGPIN-2017-04980
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.89万
  • 财政年份:
    2020
  • 负责人:
    Filep, Janos
  • 依托单位:
Regulation of neutrophil function through the pleiotropic receptor FPR2/ALX
  • 批准号:
    RGPIN-2017-04980
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.89万
  • 财政年份:
    2018
  • 负责人:
    Filep, Janos
  • 依托单位:
Regulation of neutrophil function through the pleiotropic receptor FPR2/ALX
  • 批准号:
    RGPIN-2017-04980
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.89万
  • 财政年份:
    2017
  • 负责人:
    Filep, Janos
  • 依托单位:
国内基金
海外基金
Mettl3/Syk/MAPK通路调控中性粒细胞胞 外诱捕网 (neutrophil extracellular traps, NETs)的形成对脓毒症急性肺损 伤影响的分子机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    罗舒华
  • 依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
  • 批准号:
    82371799
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    杨程德
  • 依托单位:
IFITM1+ IL1RAP+ neutrophil通过调控巨噬细胞表型转换驱动ALPPS肝再生的机制研究
  • 批准号:
    82370624
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    吕涛
  • 依托单位:
基于Neutrophil-DCs-naive T细胞轴研究“脱敏定喘汤”调体治疗中性粒细胞型过敏性哮喘的机制
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    周玉美
  • 依托单位: